لیپوآتروفی
Sign in to saveLipoatrophy is the term describing the localized loss of fat tissue. This may occur as a result of subcutaneous injections of insulin in the treatment of diabetes, from the use of human growth hormone or from subcutaneous injections of copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site. Lipoatrophy occurs in HIV-associated lipodystrophy, one cause of which is an adverse drug reaction that is associated with some antiretroviral medications.
In the Vinony graph
Vinony's link graph records 27 inbound references to لیپوآتروفی, and connects out to adipose tissue, diabetes and digital object identifier.
It is catalogued under the topic Symptoms and signs.
Vinony links it to 8 Wikipedia language editions.
Health references
- ICD-10
- E88.10 — Lipodystrophy, unspecified
Clinical Trials
216 registered- NACOMPLETEDA Study of Amprenavir in Patients With Protease Inhibitor-Related ComplicationsGlaxo Wellcome · NCT00002417
- NACOMPLETED[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant TherapyUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology · NCT06982053
- COMPLETEDPerformance and Safety of the Lipo-transfer Cannulas in Patients Underlying Lipofilling TreatmentAesthetic Group · NCT06089759
- AVAILABLEExpanded Access Metreleptin StudyUniversity of Michigan · NCT02404896
- COMPLETEDMetabolism and Body Shape of Healthy Children and Children With Chronic InfectionsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT00001142
- NACOMPLETEDEplerenone in HIV Associated Abdominal Fat AccumulationMassachusetts General Hospital · NCT01405456